Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about MRK

Recent news which mentions MRK

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
This Adobe Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Tickers ADBE AIG MRK NEWS
Tags News AIG PANW
From Benzinga
Bullish Outlook On Instil Bio's Investigational Cancer Drug: Jefferies Sees Over 300% Stock Upside
Tickers BNTX MRK NEWS SMMT
Tags BNTX Biotech Analyst Ratings
From Benzinga
Unpacking the Latest Options Trading Trends in Merck & Co
Tickers MRK
Tags MRK Options BZI/UOA
From Benzinga
Merck Buys WuXi Vaccines' Irish Manufacturing Facility For Over $500 Million
Tickers MRK NEWS
Tags Benzinga Contracts Market News
From Benzinga
Viking Therapeutics, Structure Therapeutics Positioned As Key Pharma Partners For Weight Loss Products: Analyst
Tickers GPCR LLY MRK NEWS
Tags News LLY Expert Ideas
From Benzinga
Why Viking Therapeutics Stock Plummeted by 24% in December
Tickers MRK VKTX
Tags MRK Market News VKTX
From Motley Fool
Should You Buy the Dip on This High-Flying Stock?
Tickers MRK VKTX
Tags Recent Press Releases VKTX Market News
From Motley Fool
UK Approves Merck's Hypertension Drug Acquired Via $11 Billion Acceleron Pharma Deal
Tickers MRK NEWS
Tags Top Stories News Market News
From Benzinga
Dogs Of The Dow: Top 10 High-Yield Stocks Offering Dividends Up To 6.8% In 2025
Tickers AMGN AMZN BA CSCO
Tags WBA Dow Jones Industrial Average MRK
From Benzinga
2 High-Yield Dividend Stocks to Buy Early in 2025
Tickers BMY MRK
Tags Recent Press Releases Market News MRK
From Motley Fool
Will This Major Pharmaceutical Stock Announce a Stock Split in 2025?
Tickers GS LLY MRK NVDA
Tags NVS LLY WMT
From Motley Fool
3 Stocks That Could Be Monster Winners in 2025
Tickers MRK NVO SMMT VKTX
Tags AKES/F Recent Press Releases MRK
From Motley Fool
2 Reasons to Sell Merck Stock and 1 Reason to Buy
Tickers MRK
Tags Recent Press Releases Market News MRK
From Motley Fool
Top 7 Blue-Chip Stocks With The Best Return Potential Going Into 2025
Tickers AMZN CAT CRM CVX
Tags Trading Ideas NVDA Evercore ISI
From Benzinga
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Tickers ABBV BMY ELAN GILD
Tags ELAN Benzinga Health Care
From Benzinga
Is Merck the Next Big Weight-Loss Stock?
Tickers LLY MRK NVO
Tags NVO Recent Press Releases Market News
From Motley Fool
Down 18% in 1 Day, Is Viking Therapeutics Stock in Trouble Due to Merck?
Tickers MRK VKTX
Tags MRK Recent Press Releases VKTX
From Motley Fool
Why Viking Therapeutics Tumbled by More Than 10% This Week
Tickers LLY MRK NVO VKTX
Tags Recent Press Releases LLY VKTX
From Motley Fool
Want to Collect a Dividend Every Month? Invest in These 3 High-Yielding Income Stocks
Tickers CVX MRK T
Tags MRK T Recent Press Releases
From Motley Fool
3 Stocks That Could Turn $1,000 into $5,000 by 2030
Tickers GOOG GOOGL MRK MRNA
Tags MRNA TSLA Recent Press Releases
From Motley Fool
Merck's Investigational Two-Drug Regime For HIV Meets Primary Goal In Two Late-Stage Trials
Tickers MRK NEWS
Tags News Top Stories General
From Benzinga
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
Tickers BMY CI CNC CVS
Tags News IHE LLY
From Benzinga
Stock Of The Day: Where Does The Merck Downtrend End?
Tickers HNSPF MRK PSNL
Tags HNSPF Technicals PSNL
From Benzinga
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
Tickers MRK NEWS RHHBY SNY
Tags Biotech TEVA why it's moving
From Benzinga
What's Going On With Viking Therapeutics Stock On Wednesday?
Tickers MRK NEWS VKTX
Tags News Top Stories Expert Ideas
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Tickers CI CRDF HIMS LLY
Tags NVO Benzinga NMRA
From Benzinga
What's Going On With Merck Shares Wednesday?
Tickers MRK NEWS
Tags Market News Movers Benzinga
From Benzinga
Merck Discontinues Certain Cancer Candidate Trials After Futility Analysis
Tickers MRK NEWS
Tags News Biotech Briefs
From Benzinga
Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report
Tickers AMGN AZN BMY EXEL
Tags Biotech JNJ NVS
From Benzinga
Bicycle Therapeutics Lead Cancer Drug Combined With Merck's Blockbuster Drug Shows 60% Overall Response Rate In Urothelial Cancer Patients
Tickers BCYC MRK NEWS
Tags Market News Briefs General
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.